Hypothalamic neuron energy metabolism

Hypothalamic neuron energy metabolism is a complex physiological process rather than a single molecular target. It involves the integration of peripheral signals—such as leptin, insulin, and glucose—by specialized neuronal populations in the hypothalamus, primarily the pro-opiomelanocortin (POMC) and agouti-related peptide (AgRP) neurons (Morton et al., Nature, 2006). These neurons utilize intracellular energy sensors like AMP-activated protein kinase (AMPK) and the mechanistic target of rapamycin (mTOR) to adjust cellular activity, which in turn dictates systemic appetite and energy expenditure (Lopez et al., Cell Metab, 2007). Dysregulation of this metabolic sensing is a hallmark of obesity and metabolic syndrome, often manifesting as central resistance to satiety hormones (Blouet & Schwartz, CNS Neurol Disord Drug Targets, 2010). While the process itself is not a discrete drug target, many of its components, including the Melanocortin 4 receptor (MC4R) and Glucagon-like peptide 1 receptor (GLP-1R), are successfully targeted by anti-obesity medications like setmelanotide and semaglutide (PubChem, 2024). Consequently, understanding the metabolic state of these neurons is critical for developing therapies that address the underlying causes of metabolic disease (NIH, 2023).

Other names

Central energy sensingHypothalamic metabolic integrationHomeostatic regulation of energy balanceHypothalamic nutrient sensing

Modulation of neuronal firing rates and intracellular signaling cascades (e.g., AMPK, mTOR, and PI3K pathways) in the hypothalamus to integrate peripheral hormonal and nutrient signals for the regulation of systemic energy balance.